Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , |
Tipo de documento: | Artigo (review) |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.7150/jca.16629 http://repositorio.unifesp.br/handle/11600/49268 |
Resumo: | Cancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field. |
id |
UFSP_c928c17d15f39d51f86a8597e777636a |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/49268 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologiesGastrointestinal CancerIps CellsHuman FibroblastsDefined FactorsSomatic-CellsGenerationInductionEfficientHypoxiaGenomeCancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field.Laboratory of Genetics, Butantan Institute, Av. Vital Brasil 1500, 05503900 Sao Paulo, SP, BrazilDepartment of Morphology and Genetics, Universidade Federal de Sao Paulo, Sao Paulo, SP, BrazilDepartment of Morphology and Genetics, Universidade Federal de Sao Paulo, Sao Paulo, SP, BrazilWeb of ScienceFAPESP (Sao Paulo Research Foundation) [2010/51051-6]FAPESP: 2010/51051-6Karger2019-01-21T10:29:33Z2019-01-21T10:29:33Z2016info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersion2296-2303application/pdfhttp://dx.doi.org/10.7150/jca.16629Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016.10.7150/jca.16629WOS000393093300017.pdf1837-9664http://repositorio.unifesp.br/handle/11600/49268WOS:000393093300017engJournal Of Cancerinfo:eu-repo/semantics/openAccessDias Camara, Diana Aparecida [UNIFESP]Mambelli, Lisley InataPorcacchia, Allan SajKerkis, Irinareponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-10T00:49:25Zoai:repositorio.unifesp.br/:11600/49268Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-10T00:49:25Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
title |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
spellingShingle |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies Dias Camara, Diana Aparecida [UNIFESP] Gastrointestinal Cancer Ips Cells Human Fibroblasts Defined Factors Somatic-Cells Generation Induction Efficient Hypoxia Genome |
title_short |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
title_full |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
title_fullStr |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
title_full_unstemmed |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
title_sort |
Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies |
author |
Dias Camara, Diana Aparecida [UNIFESP] |
author_facet |
Dias Camara, Diana Aparecida [UNIFESP] Mambelli, Lisley Inata Porcacchia, Allan Saj Kerkis, Irina |
author_role |
author |
author2 |
Mambelli, Lisley Inata Porcacchia, Allan Saj Kerkis, Irina |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Dias Camara, Diana Aparecida [UNIFESP] Mambelli, Lisley Inata Porcacchia, Allan Saj Kerkis, Irina |
dc.subject.por.fl_str_mv |
Gastrointestinal Cancer Ips Cells Human Fibroblasts Defined Factors Somatic-Cells Generation Induction Efficient Hypoxia Genome |
topic |
Gastrointestinal Cancer Ips Cells Human Fibroblasts Defined Factors Somatic-Cells Generation Induction Efficient Hypoxia Genome |
description |
Cancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016 2019-01-21T10:29:33Z 2019-01-21T10:29:33Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/review |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
review |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.7150/jca.16629 Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016. 10.7150/jca.16629 WOS000393093300017.pdf 1837-9664 http://repositorio.unifesp.br/handle/11600/49268 WOS:000393093300017 |
url |
http://dx.doi.org/10.7150/jca.16629 http://repositorio.unifesp.br/handle/11600/49268 |
identifier_str_mv |
Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016. 10.7150/jca.16629 WOS000393093300017.pdf 1837-9664 WOS:000393093300017 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal Of Cancer |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
2296-2303 application/pdf |
dc.publisher.none.fl_str_mv |
Karger |
publisher.none.fl_str_mv |
Karger |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268419713794048 |